InDex Pharmaceuticals

About:

InDex Pharmaceuticals is a chronic disease with recurrent forest which involves a disability for several millions of down people.

Website: https://www.indexpharma.com/en/

Top Investors: EASME - EU Executive Agency for SMEs, Vinnova, Industrifonden, Neomed Management, SEB Venture Capital

Description:

InDex Pharmaceuticals AB is a clinical stage biopharmaceutical company building a leading immunotherapy franchise based on its TLR platform (toll-like receptors). It discovers and develops DIMS drugs (DNA-based immunomodulatory sequence) to treat diseases within a variety of therapeutic areas, including inflammation and cancer.